These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10417623)

  • 21. T regulatory cells in atopic dermatitis and subversion of their activity by superantigens.
    Ou LS; Goleva E; Hall C; Leung DY
    J Allergy Clin Immunol; 2004 Apr; 113(4):756-63. PubMed ID: 15100684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of antigen- and mitogen-induced proliferative responses of peripheral blood mononuclear cells by nonselective and isozyme selective cyclic nucleotide phosphodiesterase inhibitors.
    Essayan DM; Huang SK; Undem BJ; Kagey-Sobotka A; Lichtenstein LM
    J Immunol; 1994 Oct; 153(8):3408-16. PubMed ID: 7930566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 1,24-Dihydroxyvitamin D₃ (tacalcitol) prevents skin T-cell infiltration.
    Yamanaka KI; Kakeda M; Kitagawa H; Tsuda K; Akeda T; Kurokawa I; Gabazza EC; Kupper TS; Mizutani H
    Br J Dermatol; 2010 Jun; 162(6):1206-15. PubMed ID: 20163421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired responses of peripheral blood mononuclear cells to staphylococcal superantigen in patients with severe atopic dermatitis: a role of T cell apoptosis.
    Yoshino T; Asada H; Sano S; Nakamura T; Itami S; Tamura M; Yoshikawa K
    J Invest Dermatol; 2000 Feb; 114(2):281-8. PubMed ID: 10651987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection from T cell-mediated murine liver failure by phosphodiesterase inhibitors.
    Gantner F; Küsters S; Wendel A; Hatzelmann A; Schudt C; Tiegs G
    J Pharmacol Exp Ther; 1997 Jan; 280(1):53-60. PubMed ID: 8996181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional and biochemical evidence for diazepam as a cyclic nucleotide phosphodiesterase type 4 inhibitor.
    Collado MC; Beleta J; Martinez E; Miralpeix M; Domènech T; Palacios JM; Hernández J
    Br J Pharmacol; 1998 Mar; 123(6):1047-54. PubMed ID: 9559885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of spasmogen-stimulated Ins(1,4,5)P3 generation and functional responses by selective inhibitors of types 3 and 4 phosphodiesterase in airways smooth muscle.
    Challiss RA; Adams D; Mistry R; Nicholson CD
    Br J Pharmacol; 1998 May; 124(1):47-54. PubMed ID: 9630342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of phosphodiesterase type 4-specific inhibition on human autoreactive myelin-specific T cell clones.
    Pette M; Muraro PA; Pette DF; Dinter H; McFarland HF; Martin R
    J Neuroimmunol; 1999 Aug; 98(2):147-56. PubMed ID: 10430048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The superantigen exfoliative toxin induces cutaneous lymphocyte-associated antigen expression in peripheral human T lymphocytes.
    Zollner TM; Munk ME; Keller T; Nuber V; Boehncke WH; Kaufmann SH; Duijvestijn AM; Sterry W; Kaufmann R
    Immunol Lett; 1996 Jan; 49(1-2):111-6. PubMed ID: 8964597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of cutaneous lymphocyte-associated antigen on human CD4(+) and CD8(+) Th2 cells.
    Akdis M; Klunker S; Schliz M; Blaser K; Akdis CA
    Eur J Immunol; 2000 Dec; 30(12):3533-41. PubMed ID: 11093173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of PAF-induced expression of CD11b and shedding of L-selectin on human neutrophils and eosinophils by the type IV selective PDE inhibitor, rolipram.
    Berends C; Dijkhuizen B; de Monchy JG; Dubois AE; Gerritsen J; Kauffman HF
    Eur Respir J; 1997 May; 10(5):1000-7. PubMed ID: 9163638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro differentiation of human monocytes to macrophages: change of PDE profile and its relationship to suppression of tumour necrosis factor-alpha release by PDE inhibitors.
    Gantner F; Kupferschmidt R; Schudt C; Wendel A; Hatzelmann A
    Br J Pharmacol; 1997 May; 121(2):221-31. PubMed ID: 9154331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Staphylococcal enterotoxin B as a potent suppressant of T lymphocytes: trace levels suppress T lymphocyte proliferative responses.
    Ben-Nun A; Yossefi S
    Eur J Immunol; 1992 Jun; 22(6):1495-503. PubMed ID: 1376261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro pharmacology of the novel phosphodiesterase type 4 inhibitor, CP-80633.
    Cohan VL; Showell HJ; Fisher DA; Pazoles CJ; Watson JW; Turner CR; Cheng JB
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1356-61. PubMed ID: 8819523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential regulation of human antigen-specific Th1 and Th2 lymphocyte responses by isozyme selective cyclic nucleotide phosphodiesterase inhibitors.
    Essayan DM; Kagey-Sobotka A; Lichtenstein LM; Huang SK
    J Pharmacol Exp Ther; 1997 Jul; 282(1):505-12. PubMed ID: 9223593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential response of CD4+ V7+ and CD4+ V7- T cells to T cell receptor-dependent signals: CD4+ V7+ T cells are co-stimulation independent and anti-V7 antibody blocks the induction of anergy by bacterial superantigen.
    Soares LR; Rivas A; Ruegg C; Engleman EG
    Eur J Immunol; 1997 Jun; 27(6):1413-21. PubMed ID: 9209493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of human eosinophil respiratory burst and cyclic AMP hydrolysis by inhibitors of type IV phosphodiesterase: interaction with the beta adrenoceptor agonist albuterol.
    Dent G; Giembycz MA; Evans PM; Rabe KF; Barnes PJ
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1167-74. PubMed ID: 7996422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A human-SCID mouse model for allergic immune response bacterial superantigen enhances skin inflammation and suppresses IgE production.
    Herz U; Schnoy N; Borelli S; Weigl L; Käsbohrer U; Daser A; Wahn U; Köttgen E; Renz H
    J Invest Dermatol; 1998 Mar; 110(3):224-31. PubMed ID: 9506440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of a novel phosphodiesterase 7A and -4 dual inhibitor, YM-393059, on T-cell-related cytokine production in vitro and in vivo.
    Yamamoto S; Sugahara S; Naito R; Ichikawa A; Ikeda K; Yamada T; Shimizu Y
    Eur J Pharmacol; 2006 Jul; 541(1-2):106-14. PubMed ID: 16780833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of rolipram on cyclic AMP levels in alveolar macrophages and lipopolysaccharide-induced inflammation in mouse lung.
    Gonçalves de Moraes VL; Singer M; Vargaftig BB; Chignard M
    Br J Pharmacol; 1998 Feb; 123(4):631-6. PubMed ID: 9517381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.